Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Allan, Jaffe"'
Autor:
Nadia Akhiyat, Vlad Vasile, Ali Ahmad, Jaskanwal Deep Sara, Valentina Nardi, Lilach O. Lerman, Allan Jaffe, Amir Lerman
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 7 (2022)
Background Elevated plasma ceramides are independent predictors of cardiovascular disease and mortality in patients with advanced epicardial coronary artery disease. Our understanding of plasma ceramides in early epicardial coronary artery disease, h
Externí odkaz:
https://doaj.org/article/38141dc8b1914d7fb86552632fb93ea0
Autor:
Stephen, Boone, W Frank, Peacock, Alan H B, Wu, Allan, Jaffe, Robert H, Christenson, Frederic M, Ettner, Shahriar, Dadkhah
Publikováno v:
Clinica Chimica Acta. 539:66-69
Sex-differences in high sensitivity troponin (hs-Tn) concentrations are well established. There is, however, limited data to guide interpretation of hs-Tn in transgender patients, particularly those receiving gender-affirming hormone therapy. Our pur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79958b6b0bae27f52f5da56637261060
https://doi.org/10.1016/j.cca.2022.12.003
https://doi.org/10.1016/j.cca.2022.12.003
Autor:
Johannes Mair, Allan Jaffe, Bertil Lindahl, Nicholas Mills, Martin Möckel, Louise Cullen, Evangelos Giannitsis, Ola Hammarsten, Kurt Huber, Konstantin Krychtiuk, Christian Mueller, Kristian Thygesen
Publikováno v:
Mair, J, Jaffe, A, Lindahl, B, Mills, N, Möckel, M, Cullen, L, Giannitsis, E, Hammarsten, O, Huber, K, Krychtiuk, K, Mueller, C & Thygesen, K 2022, ' The clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction–from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC) ', Biomarkers, vol. 27, no. 5, pp. 407-417 . https://doi.org/10.1080/1354750X.2022.2055792
Purpose: This review intends to illustrate basic principles on how to apply the Fourth Universal Definition of Myocardial Infarction (UDMI) for the diagnosis of peri-procedural myocardial infarction (MI) after percutaneous coronary interventions (PCI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f82ac0bbe00c38d510bb72c6f56c1de4
https://doi.org/10.1080/1354750x.2022.2055792
https://doi.org/10.1080/1354750x.2022.2055792
Autor:
Zi Ye, Maurice Enriquez-Sarano, Jose R. Medina-Inojosa, Christopher G. Scott, Joseph Malouf, Allan Jaffe, Marie-Annick Clavel, Hector I. Michelena
Publikováno v:
JACC: Cardiovascular Imaging. 15:947-950
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b188477cc3fac5d52e8a6ceb2bfab318
https://doi.org/10.1016/j.jcmg.2021.11.021
https://doi.org/10.1016/j.jcmg.2021.11.021
Autor:
James L, Januzzi, John M, Canty, Saumya, Das, Christopher R, DeFilippi, Gary A, Gintant, David E, Gutstein, Allan, Jaffe, Emily P, Kaushik, Christopher, Leptak, Cyrus, Mehta, Ileana, Pina, Thomas J, Povsic, Curtis, Rambaran, Rhonda F, Rhyne, Maribel, Salas, Victor C, Shi, Jacob A, Udell, Ellis F, Unger, Tanja S, Zabka, Jonathan H, Seltzer
Publikováno v:
Journal of the American College of Cardiology. 77(15)
The momentum of cardiovascular drug development has slowed dramatically. Use of validated cardiac biomarkers in clinical trials could accelerate development of much-needed therapies, but biomarkers have been used less for cardiovascular drug developm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::76fc882b78dd9efbb144709c0cb31440
https://pubmed.ncbi.nlm.nih.gov/33858628
https://pubmed.ncbi.nlm.nih.gov/33858628
Autor:
Yariv Gerber, Susan Weston, Maurice Enriquez-Sarano, Allan Jaffe, Sheila Manemann, Ruoxiang Jiang, Veronique L Roger
Publikováno v:
Circulation. 135
Background: Current AHA/ACC guidelines recommend the GRACE and TIMI scores for assessing myocardial infarction (MI) prognosis. With recent major changes in the epidemiology of MI and new biomarkers available for risk stratification, an updated assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e446db84db23b1ec0c5965dc2794e6c
https://doi.org/10.1161/circ.135.suppl_1.mp009
https://doi.org/10.1161/circ.135.suppl_1.mp009
Autor:
Kristian Thygesen, Joseph Alpert, Allan Jaffe, Maarten Simoons, Berbard Chaitman, Harvey White
Publikováno v:
Srce i krvni sudovi. 32:29-46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eef08bd526b95a5638a47cef49fea31f
https://doi.org/10.5937/siks1301029t
https://doi.org/10.5937/siks1301029t
Autor:
Wouter C, Meijers, A Rogier, van der Velde, Anneke C, Muller Kobold, Janneke, Dijck-Brouwer, Alan H, Wu, Allan, Jaffe, Rudolf A, de Boer
Publikováno v:
European Journal of Heart Failure
Aims Biomarkers can be used for diagnosis, risk stratification, or management of patients with heart failure (HF). Knowledge about the biological variation is needed for proper interpretation of serial measurements. Therefore, we aimed to determine a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eb1a2373a4318776972c5e08bbe12a8c
https://pubmed.ncbi.nlm.nih.gov/27766733
https://pubmed.ncbi.nlm.nih.gov/27766733
Autor:
Linnea Baudhuin, Sandra Bryant, Grant Spears, Stacy Hartman, Virend Somers, Peter Berger, Joseph McConnell, Allan Jaffe
Publikováno v:
Circulation. 132
Introduction: Elevated plasma levels of lipoprotein(a) [Lp(a)] are associated with increased risk for coronary artery disease (CAD), but the strength of the association and whether it is independent of other risk factors remains controversial. Differ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::560f9adf16e24f9f1128f90890f3eb27
https://doi.org/10.1161/circ.132.suppl_3.11043
https://doi.org/10.1161/circ.132.suppl_3.11043